Racial differences in persistence to secondary prevention medication regimens after ischemic stroke

References

• Adams, R. J., G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, et al. 2008. “Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack.” Stroke 39 (5): 1647–1652. doi:10.1161/STROKEAHA.107.189063.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B., M. Liao, and L. Mosca. 2013. “Medication Adherence is Associated with Having a Caregiver among Cardiac Patients.” Annals of Behavioral Medicine 46 (2): 237–242. doi:10.1007/s12160-013-9492-8.
   PubMed Web of Science ®Google Scholar
• Aikens, J. E., A. M. Rosland, and J. D. Piette. 2015. “Improvements in Illness Self-Management and Psychological Distress Associated with Telemonitoring Support for Adults with Diabetes.” Primary Care Diabetes 9 (2): 127–134. doi:10.1016/j.pcd.2014.06.003.
   PubMed Web of Science ®Google Scholar
• Albers, G. W., P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal. 2008. “Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).” Chest 133 (6 Suppl): 630S–669S. doi:10.1378/chest.08-0720.
   PubMed Web of Science ®Google Scholar
• Amarenco, P., J. Bogousslavsky, A. Callahan, 3rd, L. B. Goldstein, M. Hennerici, A. E. Rudolph, H. Sillesen, et al. 2006. “High-dose Atorvastatin After Stroke or Transient Ischemic Attack.” New England Journal of Medicine 355 (6): 549–559. doi:10.1056/NEJMoa061894.
   PubMed Web of Science ®Google Scholar
• Burn, J., M. Dennis, J. Bamford, P. Sandercock, D. Wade, and C. Warlow. 1994. “Long-term Risk of Recurrent Stroke After a First-Ever Stroke. The Oxfordshire Community Stroke Project.” Stroke 25 (2): 333–337.
   PubMed Web of Science ®Google Scholar
• Bushnell, C. D., D. M. Olson, X. Zhao, W. Pan, L. O. Zimmer, L. B. Goldstein, M. J. Alberts, et al. 2011. “Secondary Preventive Medication Persistence and Adherence 1 Year After Stroke.” Neurology 77 (12): 1182–1190. doi:10.1212/WNL.0b013e31822f0423.
   PubMed Web of Science ®Google Scholar
• Clark, T. G., M. F. Murphy, and P. M. Rothwell. 2003. “Long Term Risks of Stroke, Myocardial Infarction, and Vascular Death in ‘Low Risk’ Patients with a non-Recent Transient Ischaemic Attack.” Journal of Neurology, Neurosurgery, and Psychiatry 74 (5): 577–580. doi:10.1136/jnnp.74.5.577.
   PubMed Web of Science ®Google Scholar
• Coull, A. J., J. K. Lovett, P. M. Rothwell, and Study Oxford Vascular. 2004. “Population Based Study of Early Risk of Stroke After Transient Ischaemic Attack or Minor Stroke: Implications for Public Education and Organisation of Services.” BMJ (Clinical Research) 328 (7435): 326. doi:10.1136/bmj.37991.635266.44.
   PubMedGoogle Scholar
• Cruz-Flores, S., A. Rabinstein, J. Biller, M. S. Elkind, P. Griffith, P. B. Gorelick, G. Howard, et al. 2011. “Racial-ethnic Disparities in Stroke Care: The American Experience: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association.” Stroke 42 (7): 2091–2116. doi:10.1161/STR.0b013e3182213e24.
   PubMed Web of Science ®Google Scholar
• Ferguson, C., S. C. Inglis, P. J. Newton, S. Middleton, P. S. Macdonald, and P. M. Davidson. 2017. “Barriers and Enablers to Adherence to Anticoagulation in Heart Failure with Atrial Fibrillation: Patient and Provider Perspectives.” Journal of Clinical Nursing 26 (23–24): 4325–4334. doi:10.1111/jocn.13759.
   PubMed Web of Science ®Google Scholar
• Flack, J. M., K. C. Ferdinand, and S. A. Nasser. 2003. “Epidemiology of Hypertension and Cardiovascular Disease in African Americans.” Journal of Clinical Hypertension (Greenwich) 5 (1 Suppl 1): 5–11.
   PubMedGoogle Scholar
• Gellad, W. F., J. S. Haas, and D. G. Safran. 2007. “Race/Ethnicity and Nonadherence to Prescription Medications among Seniors: Results of a National Study.” Journal of General Internal Medicine 22 (11): 1572–1578. doi:10.1007/s11606-007-0385-z.
   PubMed Web of Science ®Google Scholar
• Hackam, D. G., and J. D. Spence. 2007. “Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study.” Stroke 38 (6): 1881–1885. doi:10.1161/STROKEAHA.106.475525.
   PubMed Web of Science ®Google Scholar
• Haley, W. E., D. L. Roth, B. Kissela, M. Perkins, and G. Howard. 2011. “Quality of Life After Stroke: A Prospective Longitudinal Study.” Quality of Life Research 20 (6): 799–806. doi:10.1007/s11136-010-9810-6.
   PubMed Web of Science ®Google Scholar
• Hardie, K., G. J. Hankey, K. Jamrozik, R. J. Broadhurst, and C. Anderson. 2004. “Ten-year Risk of First Recurrent Stroke and Disability After First-Ever Stroke in the Perth Community Stroke Study.” Stroke 35 (3): 731–735. doi:10.1161/01.STR.0000116183.50167.D9.
   PubMed Web of Science ®Google Scholar
• Howard, V. J., M. Cushman, L. Pulley, C. R. Gomez, R. C. Go, R. J. Prineas, A. Graham, C. S. Moy, and G. Howard. 2005. “The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design.” Neuroepidemiology 25 (3): 135–143. doi:10.1159/000086678.
   PubMed Web of Science ®Google Scholar
• Howard, G., B. M. Kissela, D. O. Kleindorfer, L. A. McClure, E. Z. Soliman, S. E. Judd, J. D. Rhodes, et al. 2016. “Differences in the Role of Black Race and Stroke Risk Factors for First vs. Recurrent Stroke.” Neurology 86 (7): 637–642. doi:10.1212/WNL.0000000000002376.
   PubMed Web of Science ®Google Scholar
• Huxley, R. R., E. J. Bell, P. L. Lutsey, C. Bushnell, E. Shahar, W. Rosamond, R. Gottesman, and A. Folsom. 2014. “A Comparative Analysis of Risk Factors for Stroke in Blacks and Whites: The Atherosclerosis Risk in Communities Study.” Ethnicity & Health 19 (6): 601–616. doi:10.1080/13557858.2013.857765.
   PubMed Web of Science ®Google Scholar
• Kronish, I. M., M. A. Diefenbach, D. E. Edmondson, L. A. Phillips, K. Fei, and C. R. Horowitz. 2013. “Key Barriers to Medication Adherence in Survivors of Strokes and Transient Ischemic Attacks.” Journal of General Internal Medicine 28 (5): 675–682. doi:10.1007/s11606-012-2308-x.
   PubMed Web of Science ®Google Scholar
• Lackland, D. T. 2014. “Racial Differences in Hypertension: Implications for High Blood Pressure Management.” American Journal of the Medical Sciences 348 (2): 135–138. doi:10.1097/MAJ.0000000000000308.
   PubMed Web of Science ®Google Scholar
• Lauffenburger, J. C., J. G. Robinson, C. Oramasionwu, and G. Fang. 2014. “Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction.” Circulation 129 (7): 754–763. doi:10.1161/CIRCULATIONAHA.113.002658.
   PubMed Web of Science ®Google Scholar
• Lemstra, M., C. Nwankwo, Y. Bird, and J. Moraros. 2018. “Primary Nonadherence to Chronic Disease Medications: A Meta-Analysis.” Patient Preference and Adherence 12: 721–731. doi:10.2147/PPA.S161151.
   PubMed Web of Science ®Google Scholar
• Leung, D. Y., X. Bai, A. Y. Leung, B. C. Liu, and I. Chi. 2015. “Prevalence of Medication Adherence and Its Associated Factors among Community-Dwelling Chinese Older Adults in Hong Kong.” Geriatrics & Gerontology International 15 (6): 789–796. doi:10.1111/ggi.12342.
   PubMed Web of Science ®Google Scholar
• Lummis, H. L., I. S. Sketris, G. J. Gubitz, M. R. Joffres, and G. J. Flowerdew. 2008. “Medication Persistence Rates and Factors Associated with Persistence in Patients Following Stroke: A Cohort Study.” BMC Neurologyl 8: 25. doi:10.1186/1471-2377-8-25.
   PubMed Web of Science ®Google Scholar
• Manteuffel, M., S. Williams, W. Chen, R. R. Verbrugge, D. G. Pittman, and A. Steinkellner. 2014. “Influence of Patient Sex and Gender on Medication Use, Adherence, and Prescribing Alignment with Guidelines.” Journal Womens Health (Larchmt) 23 (2): 112–119. doi:10.1089/jwh.2012.3972.
   PubMed Web of Science ®Google Scholar
• Mathes, T., T. Jaschinski, and D. Pieper. 2014. “Adherence Influencing Factors – a Systematic Review of Systematic Reviews.” Archives of Public Health 72 (1): 37. doi:10.1186/2049-3258-72-37.
   PubMedGoogle Scholar
• McGinnis, J. M., and W. Foege. 2000. “Guide to Community Preventive Services: Harnessing the Science.” American Journal of Preventive Medicine 18: 1–2.
   PubMed Web of Science ®Google Scholar
• Nwankwo, T., S. S. Yoon, V. Burt, and Q. Gu. 2013. “Hypertension among Adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.” NCHS Data Brief 133: 1–8.
   PubMedGoogle Scholar
• Roccella, E. J. 2002. “The Contributions of Public Health Education Toward the Reduction of Cardiovascular Disease Mortality: Experiences from the National High Blood Pressure Education Program.” In Public Health Communication, edited by R. C. Hornik, 73–83. Mahwah, NJ: Lawrence Erlbaum Associates.
   Google Scholar
• Romero, J. R., J. Morris, and A. Pikula. 2008. “Stroke Prevention: Modifying Risk Factors.” Therapeutic Advances in Cardiovascular Disease 2 (4): 287–303. doi:10.1177/1753944708093847.
   PubMedGoogle Scholar
• Roth, D. L., W. E. Haley, O. J. Clay, M. Perkins, J. S. Grant, J. D. Rhodes, V. G. Wadley, B. Kissela, and G. Howard. 2011. “Race and Gender Differences in 1-Year Outcomes for Community-Dwelling Stroke Survivors with Family Caregivers.” Stroke 42 (3): 626–631. doi:10.1161/STROKEAHA.110.595322.
   PubMed Web of Science ®Google Scholar
• Sacco, R. L., R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, et al. 2006. “Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology Affirms the Value of This Guideline.” Stroke 37 (2): 577–617. doi:10.1161/01.STR.0000199147.30016.74.
   PubMed Web of Science ®Google Scholar
• Saha, S., M. Freeman, J. Toure, K. M. Tippens, C. Weeks, and S. Ibrahim. 2008. “Racial and Ethnic Disparities in the VA Health Care System: A Systematic Review.” Journal of General Internal Medicine 23 (5): 654–671. doi:10.1007/s11606-008-0521-4.
   PubMed Web of Science ®Google Scholar
• Shaya, F., A. Gu, and E. Saunders. 2006. “Addressing Cardiovascular Disparities Through Community Interventions.” Ethnicity & Disease 16: 138–144.
   PubMed Web of Science ®Google Scholar
• Sheehan, O. C., J. Prvu-Bettger, J. Huang, W. E. Haley, J. David Rhodes, E. Judd S, M. L. Kilgore, and D. L. Roth. 2018. “Is Self or Caregiver Report Comparable to Medicare Claims Indicators of Healthcare Utilization After Stroke?” Topics in Stroke Rehabilitation, 1–6. doi:10.1080/10749357.2018.1493251.
   PubMed Web of Science ®Google Scholar
• Sheinart, K. F., S. Tuhrim, D. R. Horowitz, J. Weinberger, M. Goldman, and J. H. Godbold. 1998. “Stroke Recurrence is More Frequent in Blacks and Hispanics.” Neuroepidemiology 17 (4): 188–198. doi:10.1159/000026172.
   PubMed Web of Science ®Google Scholar
• Shorter, H. 1993. “Noncompliance with Medications: An economic Tragedy with Important Implications for Health Care Reform.” Task Force for Compliance Report.
   Google Scholar
• Touze, E., O. Varenne, G. Chatellier, S. Peyrard, P. M. Rothwell, and J. L. Mas. 2005. “Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis.” Stroke 36 (12): 2748–2755. doi:10.1161/01.STR.0000190118.02275.33.
   PubMed Web of Science ®Google Scholar
• Tsai, J. P., P. A. Rochon, S. Raptis, S. E. Bronskill, C. M. Bell, and G. Saposnik. 2014. “A Prescription at Discharge Improves Long-Term Adherence for Secondary Stroke Prevention.” Journal of Stroke and Cerebrovascular Diseases 23 (9): 2308–2315. doi:10.1016/j.jstrokecerebrovasdis.2014.04.026.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. 2019. “Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among US Adults Aged 18 Years and Older Applying the Criteria From the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline – NHANES 2013–2016”.Centers for Disease Control and Prevention (CDC) Atlanta, GA.
   Google Scholar
• van Wijk, I., L. J. Kappelle, J. van Gijn, P. J. Koudstaal, C. L. Franke, M. Vermeulen, J. W. Gorter, A. Algra, and L. A. C. study group Li. 2005. “Long-term Survival and Vascular Event Risk After Transient Ischaemic Attack or Minor Ischaemic Stroke: A Cohort Study.” Lancet 365 (9477): 2098–2104. doi:10.1016/S0140-6736(05)66734-7.
   PubMed Web of Science ®Google Scholar
• Vinogradova, Y., C. Coupland, P. Brindle, and J. Hippisley-Cox. 2016. “Discontinuation and Restarting in Patients on Statin Treatment: Prospective Open Cohort Study Using a Primary Care Database.” BMJ 353: i3305. doi:10.1136/bmj.i3305.
   PubMedGoogle Scholar
• WHO (World Health Organization). 2003. “Adherence to Long-term Therapies: Evidence for action”.
   Google Scholar
• Winkleby, M. A. 1994. “The Future of Community-Based Cardiovascular Disease Intervention Studies.” American Journal of Public Health 84: 1369–1371.
   PubMed Web of Science ®Google Scholar